Company intelligence / Profile preview

PhotonMD

Durham, North Carolina, United Statesprnewswire.com ↗

Ownership: Private
Development stage: Other

Overview

PhotonMD has developed the REVIAN RED System, an FDA-cleared wireless wearable cap using proprietary dual-wavelength LED light to treat androgenetic alopecia. In a randomized, double-blind, placebo-controlled pivotal trial designed to pharmaceutical standards, the device demonstrated statistically significant ability to stop hair loss and promote new hair growth. The safety profile was excellent. The product offers an alternative to topical minoxidil or oral finasteride without pharmaceutical side effects. Full clinical results are expected to be published in peer-reviewed literature.

Therapeutic areas: Dermatology
Modalities: DeviceNon-pharmacological therapy (specifically medical-grade LED light therapy)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on PhotonMD.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PhotonMD.

Explore the full profile